Assessment of Recovery After Adductor Canal Block Analgesia in Unilateral Prosthetic Knee Surgery
IPACKNEE
1 other identifier
interventional
130
1 country
1
Brief Summary
The purpose of the study is post-operative recovery from prosthetic knee surgery will be assessed by the proportion of patients entering the Accelerated Rehabilitation After Surgery program eligible for discharge from hospital at 2 days according to the following definition: Chung score ≥ 9 with no intravenous (IV) infusion, solid food, transit restored, no signs of infection and Cumulated Ambulation Score D1 ≥ 5 (if discharged on Day 1), Cumulated Ambulation Score Day 2 ≥ 10 (if discharged on Day 2), or Cumulated Ambulation Score Day 3 ≥ 11/18.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 26, 2023
CompletedFirst Posted
Study publicly available on registry
February 8, 2023
CompletedStudy Start
First participant enrolled
April 5, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 19, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 19, 2025
CompletedApril 1, 2026
March 1, 2026
2 years
January 26, 2023
March 27, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Post-operative recovery from knee prosthesis surgery
Post-operative recovery from prosthetic knee surgery will be assessed by the proportion of patients entering the Accelerated Rehabilitation After Surgery program eligible for discharge from hospital at 2 days according to the following definition: Chung score ≥ 9 with no intravenous (IV) infusion, solid food, transit restored, no signs of infection and Cumulated Ambulation Score D1 ≥ 5 (if discharged on Day 1), Cumulated Ambulation Score Day 2 ≥ 10 (if discharged on Day 2), or Cumulated Ambulation Score Day 3 ≥ 11/18.
3 days
Study Arms (2)
Block at the Adductor Canal + Infiltration between Popliteal Artery and Posterior Capsule
EXPERIMENTALAdductor canal block analgesia associated with infiltration between the popliteal artery and the posterior capsule
Block at the Adductor Canal + High Volume Local Infiltration Analgesia
ACTIVE COMPARATORAdductor canal block analgesia associated with surgical periarticular infiltration
Interventions
Unilateral prosthetic knee surgery
Analgesic management by adductor canal block
Eligibility Criteria
You may qualify if:
- Patient with a score "American Society of Anesthesiologists" I to III;
- Patient undergoing initial unilateral prosthetic knee replacement surgery for osteoarthritis;
- Patient eligible for analgesia by block of the adductor canal associated with additional infiltration;
- Patient accepting to follow the enhanced recovery program after surgery;
- Patient who signed an informed consent form to participate in the study.
You may not qualify if:
- Patient with a known allergy to a study product;
- Patient having undergone previous surgery with a prosthesis on the knee to be operated on;
- Patient with morbid obesity (Body Mass Index \> 40);
- Patient with a pre-existing inability to walk;
- Patient with a history of chronic neuropathic pain in the leg undergoing surgery;
- Patient with heart failure with impaired ejection fraction;
- Patient with a history of drug addiction;
- Patient chronically taking level III analgesics;
- Patient taking gabapentin or pregabalin chronically;
- Patient with severe renal or hepatic impairment;
- Patient with a high level of dependence, defined by level 1 or 2 of the Iso-Ressources Group;
- Protected patient (under legal protection, or deprived of liberty by judicial or administrative decision);
- Patient unable to understand the information related to the study (linguistic, psychological, cognitive reasons, etc.);
- Pregnant or likely to be pregnant (of childbearing age without effective contraception) or breastfeeding;
- Patient not benefiting from a social security scheme.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hôpital Privé Médipôle
Villeurbanne, 69100, France
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Masking Details
- The patient and the people carrying out the functional assessments (physiotherapists) will be blinded to the analgesia received, unlike the investigator.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 26, 2023
First Posted
February 8, 2023
Study Start
April 5, 2023
Primary Completion
March 19, 2025
Study Completion
March 19, 2025
Last Updated
April 1, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share